Pharmaceutics International, Inc. (Pii) Announces Expansion Of Commercial Capabilities

HUNT VALLEY, Md., March 10, 2015 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development Manufacturing Organization (CDMO) based in Hunt Valley, MD, has announced the expansion of its commercial packaging capabilities.  The expansion of more than 18,000 sq. ft. of converted warehouse space will be at the company's Golden West facility.  The new cGMP area will include three new high speed automated bottling and powder filling lines and four blister packaging production suites, with dedicated air handling.  The completion, planned for June 2015, is a strategic decision in preparation for future commercial production of over 40 products pending FDA approval.  Steve King, Pii's Senior Vice President, noted, "The increased capacity and capabilities will support Pii's future growth and meet the growing needs of our existing and future commercial clients."

About Pharmaceutics International, Inc.

Pii is a privately held CDMO providing dosage form development and GMP manufacturing services to the global pharmaceutical industry. Headquartered in Hunt Valley, Maryland USA with European facilities in the UK, services include pre-formulation testing, formulation development, clinical and commercial GMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms, clinical packaging and labeling, clinical trial kit building and distribution, analytical and QP services. Pii's facilities include manufacturing and containment suites, automated packaging lines and a wide selection of equipment.  For more information, please visit www.pharm-int.com.

Contact:
Steve King, Senior Vice President
Pharmaceutics International, Inc.
10819 Gilroy Road
Hunt Valley, MD 21031
Phone: (410) 584-0001
Email: [email protected]

Logo - http://photos.prnewswire.com/prnh/20150310/180806LOGO

SOURCE Pharmaceutics International, Inc.

Related Links

http://www.pharm-int.com